Extent of Beta Cell Destruction Is Important but Insufficient to Predict the Onset of Type 1 Diabetes Mellitus (original) (raw)

Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans

Waldemar Uhl

Diabetologia, 2012

View PDFchevron_right

The heterogeneous pathogenesis of type 1 diabetes mellitus

Jorma Ilonen

Nature Reviews Endocrinology, 2019

View PDFchevron_right

Insulin Intervention to Preserve β Cells in Slowly Progressive Insulin-Dependent (Type 1) Diabetes Mellitusa

Azuma Kanatsuka

Annals of the New York Academy of Sciences, 2006

View PDFchevron_right

Immunogenetics of Type 1 Diabetes

Rajni Rani

Autoimmune Disorders - Pathogenetic Aspects, 2011

View PDFchevron_right

Type 1 diabetes mellitus: retrospect and prospect

Tamer Addissouky

Bulletin of the National Research Centre/Bulletin of the National Research Center, 2024

View PDFchevron_right

Type 1 diabetes in insulin-treated adult-onset diabetic subjects

Paul Zimmet

Diabetes Research and Clinical Practice, 1998

View PDFchevron_right

Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance

ANDREA NATALI

Diabetologia, 2003

View PDFchevron_right

Immunological biomarkers for the development and progression of type 1 diabetes

Timothy Tree

Diabetologia

View PDFchevron_right

Scandinavian Society for the Study of Diabetes abstracts

Jørgen Lindgaard Pedersen

Diabetologia, 1966

View PDFchevron_right

Diagnosis and Classification of Diabetes Mellitus

William Herman

Diabetes Care, 2012

View PDFchevron_right

Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes

David Meltzer

New England Journal of Medicine, 2008

View PDFchevron_right

International Journal of Diabetes and Clinical Research

Myron Szewczuk

View PDFchevron_right

PS18 - 3. Loss of beta-cell identity occurs in type 2 diabetes and is associated with islet amyloid depositions

Barbara C. Hansen

Nederlands Tijdschrift voor Diabetologie, 2013

View PDFchevron_right

A Case Series of Follow-Ups in Covid-Related Diabetes: Could the Damage in Beta Cells Be Recovered?

Márcia Nery

Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo, 2023

View PDFchevron_right

Type 2 diabetes: principles of pathogenesis and therapy

Timon van Haeften

The Lancet, 2005

View PDFchevron_right

6 Islet cell antibodies in diabetes

Carl-Henrik Brogren

1982

View PDFchevron_right

Multicenter Prevention Trial of Slowly Progressive Type 1 Diabetes with Small Dose of Insulin (the Tokyo Study)

Azuma Kanatsuka

Annals of the New York Academy of Sciences, 2003

View PDFchevron_right

Toxic Type 1 Diabetes

Paul Zimmet

2003

View PDFchevron_right

Improvements in life expectancy in type 1 diabetes patients in the last six decades

Eugenia Farcasiu

Diabetes Research and Clinical Practice, 2009

View PDFchevron_right

Circulating metabolites in progression to islet autoimmunity and type 1 diabetes

Jorma Ilonen

Yearbook of pediatric endocrinology, 2021

View PDFchevron_right

Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes

Anne Jörns

Diabetologia, 2013

View PDFchevron_right

Type 1 Diabetes versus Type 2 Diabetes with Onset in Persons Younger than 20 Years of Age

Nihal Thomas

Annals of the New York Academy of Sciences, 2008

View PDFchevron_right

Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

Tal Oron

Diabetologia, 2024

View PDFchevron_right

Diabetes epidemiology as a tool to trigger diabetes research and care

Paul Zimmet

Diabetologia, 1999

View PDFchevron_right

Biphasic effect of insulin on beta cell apoptosis depending on glucose deprivation

Manuel Benito

FEBS Letters, 2008

View PDFchevron_right

Dissection of the Pathophysiology of Type 1 Diabetes by Genetic Analysis

Soumitra Ghosh

Autoimmunity, 1993

View PDFchevron_right

European Association for the study of Diabetes First Annual Meeting, Montecatini Terme, 20. IV.-22.IV. 1965

Jose Cabezas Cerrato

Diabetologia, 1965

View PDFchevron_right

Understanding the mechanisms of reversal of type 2 diabetes

Ahmad Al-Mrabeh

The Lancet Diabetes & Endocrinology, 2019

View PDFchevron_right

Diabetic ketoacidosis at the onset of type 1 diabetes

reem ghazal

BMJ, 2011

View PDFchevron_right

Immune State Assessment in People with Diabetes Mellitus

Mohammad J Al-Jassani

The Journal of communicable diseases, 2023

View PDFchevron_right

Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced β-cell autoimmunity

Jorma Ilonen

European journal of endocrinology, 2013

View PDFchevron_right

The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System

Gholamreza Daryabor

Frontiers in Immunology, 2020

View PDFchevron_right

Exocrine pancreas function decreases during the progression of the beta‐cell damaging process in young prediabetic children

Jorma Ilonen

Pediatric Diabetes, 2017

View PDFchevron_right

35th Annual Meeting of the European Association for the Study of Diabetes

Ingrid Kloting

Diabetologia, 1999

View PDFchevron_right

Diabetes, complications and limit cycles

Silvere Nuiro

HAL (Le Centre pour la Communication Scientifique Directe), 2015

View PDFchevron_right